Stock Price Quote

VIJAYA DIAGNOSTIC CENTRE LTD.

NSE : VIJAYABSE : 543350ISIN CODE : INE043W01024Industry : Hospital & Healthcare ServicesHouse : Private
BSE1026.95-34.35 (-3.24 %)
PREV CLOSE ( ) 1061.30
OPEN PRICE ( ) 1085.95
BID PRICE (QTY) 1026.55 (17)
OFFER PRICE (QTY) 1027.95 (45)
VOLUME 8669
TODAY'S LOW / HIGH ( )1023.55 1085.95
52 WK LOW / HIGH ( )654.75 1276.75
NSE1024.70-37.1 (-3.49 %)
PREV CLOSE( ) 1061.80
OPEN PRICE ( ) 1068.00
BID PRICE (QTY) 1024.10 (61)
OFFER PRICE (QTY) 1024.40 (3)
VOLUME 217444
TODAY'S LOW / HIGH( ) 1022.00 1081.60
52 WK LOW / HIGH ( )654.55 1275
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 05-06 2002
Management Info
S Surendranath Reddy - Chairman Suprita Reddy Sura - Managing Director
Registered Office

Address 6-3-883/ F , F P A Building,Near Topaz Building,Punjagutta,
Hyderabad,
Telangana-500082

Phone 040 2342 0411-12

Email info@vijayadiagnostic.com

Website www.vijayadiagnostic.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

20Feb Vijaya Diagnostic Centre informs abo
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
18Feb Vijaya Diagnostic Centre informs about
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
10Feb Vijaya Diagnostic Centre informs about
Vijaya Diagnostic Centre has informed that the officials of the Company..
18Nov Vijaya Diagnostic Centre informs about
Vijaya Diagnostic Centre has informed that it enclosed details of the pr..
14Aug Vijaya Diagnostic Centre informs about
In compliance with the provisions of the Companies Act, 2013 (‘the Act’)..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit335.311146.02
Gross Profit 443.46 1524.72
Operating Profit 674.672336.36
Net Sales 1562.555250.23

ROLLING FORWARD P/E (EOD)

JavaScript chart by amCharts 3.4.2Show all
JavaScript chart by amCharts 3.4.212 Months Rolling Forward P/E (X)

EVENT CALENDAR

peer group

Aashka Hospitals (BSE)
peergroup  106.25 (4.42%)
M.Cap ( in Cr)250.38
Lotus Eye Hospital (BSE)
peergroup  71.93 (6.15%)
M.Cap ( in Cr)150.77
Soni Medicare (BSE)
peergroup  67.95 (4.84%)
M.Cap ( in Cr)29.00
Asarfi Hospital Ltd. (BSE)
peergroup  90.89 (2.07%)
M.Cap ( in Cr)177.10
Krishna Inst.Medi (BSE)
peergroup  668.90 (0.27%)
M.Cap ( in Cr)26809.31

Shareholding Pattern

PROMOTERS 53.05%
NON-INSTITUTION 3.87%
MUTUAL FUNDS/UTI 23.67%
FI/BANKS/INSURANCE 0.01%
GOVERNMENT 0%
FII 0%

About Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic Centre Ltd. was incorporated in the year 2002. Its today's share price is 1026.95. Its current market capitalisation stands at Rs 10612.59 Cr. In the latest quarter, company has reported Gross Sales of Rs. 5250.23 Cr and Total Income of Rs.5496.49 Cr. The company's management includes Manjula Anagani, D Nageshwar Reddy, S Geeta Reddy, Shekhar Prasad Singh, Satyanarayana Murthy Chavali, Suprita Reddy Sura, Sunil Chandra Kondapally, S Surendranath Reddy, Hansraj Singh.

It is listed on the BSE with a BSE Code of 543350 , NSE with an NSE Symbol of VIJAYA and ISIN of INE043W01024. It's Registered office is at 6-3-883/ F , F P A Building,Near Topaz Building,PunjaguttaHyderabad-500082, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates LLP, BSR & Co

1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.
1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
Close X
OPEN

DEMAT ACCOUNT

AND START YOUR

INVESTMENT

JOURNEY WITH US
(You will receive a Call & SMS from our end)
Popup-Character

Disclaimer: NIRMAL BANG SECURITIES PVT LTD: Investment in Securities market are subject to market risks. Read all the related documents carefully before investing. Please read the Do’s and Don’ts prescribed by the Commodity Exchange before trading. We do not offer PMS Service for the Commodity segment. Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO. The securities quoted are exemplary and are not recommendatory. BSE (Member ID- 498): INB011072759, INF011072759, Exchange Registered Member in CDS; NSE MEMEBR ID- 09391): INB230939139, INF230939139, INE230939139; MSEI Member ID-1067): INB260939138, INF260939138, INE260939139: Single Registration No. INZ000202536, PMS Registration No: INP000002981; Research Analyst Registration No: INH000001766; NSDL/ CDSL: IN-DP-CDSL 37-99; Exchange Member ID: MCX - 56460, NCDEX - 1268, ICEX – 2073. Regd. Office: B-2, 301/302, 3rd Floor, Marathon Innova, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai - 400013. Tel: 62738000/01; Fax: 62738010 | *NIRMAL BANG NIVESHALAYA PVT LTD: ARN – 111233, Mutual Fund Distributor. Mutual Fund Investments are subject to market risks. Please read the offer documents carefully before Investing.” Regd. Office: B - 201, Khandelwal House, Poddar Road, Near Poddar Park, Malad (East). Mumbai – 400097. | **NIRMAL BANG INSURANCE BROKING PVT LTD: IRDAI Registration No: 795 and Registration Code For the Insurance Broker: IRDAI/DB889/2021. Insurance is the subject matter of the solicitation. For more details on policy terms, conditions, exclusions, limitations, please refer/read policy brochure carefully before concluding sale.